News
KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, the first on-demand oral ...
MONDAY, July 7, 2025 — Two babies in Oregon got sick with lead poisoning after eating baby food from Target that was ...
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
WASHINGTON — The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s ...
The drug gained a following in some circles for its supposed ability to treat COVID-19 safely, something all major medical ...
The FDA granted orphan drug designation to Sineugene Therapeutics' SNUG01, a first-in-class experimental gene therapy for ...
As Chinese-developed drugs draw U.S. interest, a regulatory chill threatens to dampen new investment
Those questions, experts say, are based on the Trump administration’s hawkish approach to China generally, as well as on a ...
In an ongoing Phase 1 trial published in Nature Medicine, MB-101 was well-tolerated and 50% of patients achieved stable ...
1don MSN
NIH budget cuts are threatening key medical research programs, shrinking training grants, and leaving young researchers ...
These recent food recalls involve cream cheese, eggs, shrimp, and ice cream due to serious health risks including salmonella ...
Americans are increasingly demanding that chemicals and toxic food dyes be removed from items they consume, clean with, wear, ...
KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug for a type of hereditary swelling disorder, sending its shares up 33.3% in premarket trading.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results